跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Creon 10000 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Creon 10000
Approved
STANDARD
Creon 10000
Abbott Laboratories GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6995c183f08714bf
Company
Abbott Laboratories GmbH
Type
Standard
Approval Details
Approval Id
6995c183f08714bf
Drug Approval Philippines Name
Creon 10000
Product Name
Creon 10000
Registration Number
DR-XY45454
Brand Name
Creon 10000
Generic Name
Pancreatin
Dosage Form
Capsule
Dosage Strength
Formulation: Each capsule is filled with enteric-coated minimicrospheres for oral administration containing 150 mg Pancreatin (pancreas powder) corresponding to: Lipase-10000 Ph. Eur. Units Amylase- 8000 Ph. Eur. Units Protease-600 Ph. Eur. Units
Manufacturer
Abbott Laboratories GmbH
Trader
Abbott Laboratories GmbH
Importer
Abbott Laboratories
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/abbott-laboratories-gmbh
Trader Detail Path
/organization/abbott-laboratories-gmbh
Importer Detail Path
/organization/abbott-laboratories
Issuance Date
26 March 2021
Expiry Date
20 June 2026
Pharmacologic Category
Digestive Enzyme Supplement
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6995c183f08714bf
Type
Standard
Back to Philippines FDA Approvals